A novel 1745-dalton pyroglutamyl peptide derived from chromogranin B is in the bovine adrenomedullary chromaffin vesicle |
| |
Authors: | T Flanagan L Taylor L Poulter O H Viveros E J Diliberto Jr |
| |
Institution: | Division of Medicinal Biochemistry, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709. |
| |
Abstract: | 1. Following the recent demonstration of a glutaminyl cyclase activity localized in adrenomedullary chromaffin vesicles, an assay was developed to isolate and characterize posttranslationally modified peptides from this tissue which contain pyroglutamate. This assay consisted of spectrometric identification of peptides before and after enzymatic removal of pyroglutamyl residues. 2. Using this procedure, a pyroglutamyl peptide (BAM-1745) was isolated and sequenced and was shown to be a significant component of adrenomedullary secretory vesicles. 3. A computer search through the Swiss-Prot protein sequence database revealed a 93% identity of BAM-1745 and a fragment of human chromogranin B (Gln580-Tyr593). |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |